Innoviz Technologies Ltd. (INVZ) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
INVZ currently has 201M outstanding shares. with significant dilution risk as 116M authorized shares could dilute existing holders by 57.8%. The company has diluted shareholders by 20.07% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Aug 13, 2025 |
F-3 filing: Innoviz Technologies Ltd. is offering up to $200,000,000 of ordinary shares, warrants, or debt securities, separately or as units, and also offering ordinary shares up to $75,000,000 through an at-the-market offering with Jefferies as the sales agent. |
200M | 120M |
| Mar 12, 2025 |
20-F filing | 167.2M shares outstanding |
170M | 32M |
| Mar 12, 2024 |
20-F filing | 165.4M shares outstanding |
170M | 34M |
| Mar 09, 2023 |
20-F filing | 135.2M shares outstanding |
140M | 64M |
| Sep 29, 2022 |
F-3 filing: Innoviz Technologies Ltd. is offering up to $200,000,000 of ordinary shares, warrants to purchase ordinary shares or debt securities, debt securities or any combination of the above, separately or as units. |
130M | 64M |
| May 24, 2022 |
F-3 filing: This F-3 filing includes the offering of ordinary shares issuable upon exercise of existing warrants, as well as ordinary shares and warrants offered by Selling Securityholders, with existing warrants exercisable at $11.50 per share until April 5, 2026. |
130M | 27M |
| Mar 30, 2022 |
20-F filing | 134.1M shares outstanding |
130M | 0 |
| Oct 04, 2021 |
POS AM filing: This POS AM filing relates to the potential offering of ordinary shares and warrants by selling securityholders, as well as ordinary shares issuable upon exercise of warrants, with the company potentially receiving proceeds from warrant exercises for general corporate purposes. |
130M | 0 |
| Jul 27, 2021 |
F-1 filing: This F-1 filing outlines the offering of ordinary shares issuable upon exercise of warrants, as well as ordinary shares and warrants offered by selling securityholders. The company may receive proceeds from the exercise of warrants, while the selling securityholders will receive proceeds from their sales. |
130M | 150M |
| Apr 21, 2021 |
20-F filing | 129.8M shares outstanding |
130M | 0 |